NuvaRing Stroke and Heart Attack Side Effects

Austin Kirk

By Austin Kirk
Posted June 15, 2012


A study published this week provides further evidence about the increased risk of heart attack and stroke from NuvaRing side effects, finding that use of the birth control ring may double the risk of women suffering a thrombotic stroke or myocardial infarction.

Please note that the lawyers at Saiontz & Kirk, P.A. are no longer taking on new cases involving NuvaRing. The content on this page is provided for informational purposes only.

The NuvaRing lawyers at Saiontz & Kirk, P.A. represent women throughout the United States who are pursuing financial compensation as a result of the drug manufacturers failure to adequately warn about the risks associated with the medication. Among the injuries being reviewed are cases for women who suffered a heart attack or stroke on NuvaRing after the medication caused a blood clot.

In the study, which was published in the New England Journal of Medicine, researchers examined data involving more than 1 million Danish women that was collected over a 15 year period. They examined various different birth control methods, to evaluate what the impact was on a woman’s relative risk of suffering a thrombotic stroke (which occurs when a blood clot stops the flow of blood to the brain, killing brain cells) or a heart attack (which can occur when a blood clot blocks a coronary artery).

Researchers found that combined hormone birth control pills, which contain estrogen and progestin, were linked with an increased risk, but the highest risk of stroke and heart attacks was seen with NuvaRing and Ortho Evra patch, which deliver the hormones through a vaginal ring and skin patch, respectively.

NuvaRing, which delivers a combination of ethinyl estradiol and etonogestrel to prevent pregnancy, was associated with a 2.5 relative risk for thombotic stroke and 2.1 relative risk for myocardial infarction. While the absolute risk remains small, the study establishes that there are safer alternative birth control methods available, and further highlight how the manufacturer aggressively marketed NuvaRing without adequately warning about the risk of serious and potentially life-threatening injury.


The lawyers at Saiontz & Kirk, P.A. are continuing to review potential claims on behalf of women who may be entitled to financial compensation through a NuvaRing stroke and heart attack lawsuit, as well as claims for women who have been diagnosed with other blood clot injuries, such as pulmonary embolism, deep vein thrombosis or wrongful death.

NuvaRing cases are no longer being accepted.

No Comments • Add Your Comments

Add Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide contact information below and additional private comments if you want an attorney to contact you to review a potential case.

    The information below will not be published to this page.

  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.